FRIBERG GREGORY R (EVP, Chief R&D Officer) reported 1 transaction at BIOMARIN PHARMACEUTICAL INC
Review the transaction codes below to understand the nature of each event.
Filed: 10/1/2026ACC: 0001628280-26-064272
Officer· EVP, Chief R&D Officer
Since Feb 2026
-4.09K
Net shares
Net seller
$245.2K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
4.09K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4.09K
Price / share
$60.00
Trade value
$245.16K
% of position
7.9%
9/30/2026
51.82K→47.73K
Total
Net shares
−4.09K
Net value
-$245.16K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/30/2026 | F · Tax Withholding | −4.09K | $60.00 | $245.16K | 7.9% | 51.82K | 47.73K |
| Total | −4.09K | -$245.16K | ||||||
Derivative Transactions0
No derivative transactions reported